Investors / United States / venBio
venBio
Venture capital · San Francisco, CA, United States · North America
venBio is a life sciences venture capital firm that invests in companies developing novel therapeutics and technologies for unmet medical needs. It invests across early to late stages, from academic startups to spinouts, and tends to lead its investments.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiotechtherapeuticsdrug developmenthealthcare
Your fit with venBio
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsvenBio lists 33 checked portfolio companies on its own site and is named in 6 funding rounds, 1 of them as lead. Its most frequent entry is Growth, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (95%) and Media & Entertainment (5%). 88% of its companies are based in United States. It invests most often alongside Foresite Capital, Vivo Capital and Frazier Life Sciences.
Counts come from funding rounds that name venBio, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not venBio's whole history. Rounds on record name 6 companies; its own site lists 33. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 33% |
| Series B | 17% |
| Growth | 50% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 2 | 0 |
| '26 | 4 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 53th | 21 companies |
| Recent activity | 86th | 5 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 97th | 95% in its largest sector |
| Reach | 58th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Foresite Capital | 8 |
| Vivo Capital | 6 |
| Frazier Life Sciences | 5 |
| Samsara BioCapital | 4 |
| Sofinnova | 4 |
| Altamont Pharmaceutical Holdings | 3 |
| General Atlantic | 3 |
| Nextech Invest | 3 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2988%
- No longer answers00%
- Points to another company412%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 95% | 15% |
| Media & Entertainment | 5% | 4% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Foresite Capital
Compare venBio head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
as stated on its siteRecent portfolio activity
when companies last raised with venBio| Date | Company | Stage |
|---|---|---|
| 1 Jun 2026 | Series A Led | |
| 14 Jan 2026 | Series A | |
| 8 Jan 2026 | Series C+ | |
| 16 Dec 2025 | Series B | |
| 15 Apr 2025 | Series C+ |
Round details for venBio
Amounts, full round histories and every co-investor in venBio's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
33 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The company designs and develops ligand traps that target Activin x GDF biology to treat diseases such as pulmonary hypertension, heart failure and obesity. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Achieve Life Sciences is a late-stage specialty pharmaceutical company dedicated to tackling the global nicotine dependence epidemic by advancing cytisinicline. | Healthcare & Biotech | Portfolio page | ||
| Aeovian Pharmaceuticals develops small molecules to treat certain rare genetic and age-related diseases | Healthcare & Biotech | Dec 2025Series B | Funding round | |
| Akero Therapeutics is pioneering novel therapies to transform the lives of people living with serious metabolic diseases | Healthcare & Biotech | Portfolio page | ||
| Alumis Inc is focused on immune-mediated disease therapies | Healthcare & Biotech | Portfolio page | ||
| ALX Oncology is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives. | Healthcare & Biotech | Portfolio page | ||
| Apellis develops life-changing medicines for patients with debilitating diseases | Healthcare & Biotech | Portfolio page | ||
| Artiva Biotherapeutics is developing therapies for autoimmune diseases, including a natural killer cell therapy called AlloNK | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Attovia Therapeutics is developing next-generation biotherapeutics for immune-mediated diseases. | Healthcare & Biotech | Apr 2025Series C+ | Portfolio page | |
| Attralus develops novel therapeutics to remove toxic amyloid for the treatment of amyloidosis | Healthcare & Biotech | Portfolio page | ||
| Aurinia Pharmaceuticals develops treatments for autoimmune diseases, including lupus nephritis. | Healthcare & Biotech | Portfolio page | ||
| Axent Biosciences is a biotechnology therapeutics company developing next-generation cell therapies using engineered biomaterials. | Healthcare & Biotech | Portfolio page | ||
| Axonis Therapeutics develops medicines targeting neurological disorders | Healthcare & Biotech | Portfolio page | ||
| Caldera Therapeutics is a clinical-stage biotechnology company developing a potential first-in-class bispecific antibody for inflammatory bowel disease and other immune-mediated diseases. | Healthcare & Biotech | Jan 2026Series A | Funding round | |
| Entact Bio creates new medicines by enhancing protein function | Healthcare & Biotech | Portfolio page | ||
| Harmony Biosciences develops medicines for patients with unmet medical needs | Healthcare & Biotech | Portfolio page | ||
| HistoWiz provides automated histopathology services for researchers, including tissue specimen processing and analysis | Healthcare & Biotech | Portfolio page | ||
| Impel Pharmaceuticals develops and provides transformative therapies for people suffering from diseases with high unmet medical needs | Healthcare & Biotech | Portfolio page |
About this data
site last read 12 Nov 2026- Site
- venbio.com
- Last read
- 12 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 15 Apr 2025
- Companies checked
- 33
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get venBio's profile as data
Pull venBio's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/venbio.com
# also
GET /v1/firms/venbio.com/portfolio
GET /v1/firms/venbio.com/coinvestors
GET /v1/firms/venbio.com/news